Active Pharmaceutical Ingredients (APIs)

State-of-the-art facilities for high-potency APIs

For high potency manufacturing, we have two buildings serving these purpose. The four floor building has been existed since 2009 for the cytotoxic, steroid and vitamins d derivatives manufacturing. The seven floor building was just completed the construction last year to cope with the increasing need of HPAPI Manufacturing, ADC suite and cytotoxic filling line. All the design are compliant with high standard operation for cat 4 or as OEB 5. Each floor could be taken into as independent plant which only serve for solo category production with separate “reading the lines”.

Separate entrances, exits, and ventilation systems for each floor

Equipment under containment

Clean-in-place system

Target OEL < 0.1 µg/m3

We provide the high quality active pharmaceutical ingredients globally. We are one of the leading manufacturers of active pharmaceutical ingredients in the world.

Anticancers

Nintedanib Esylate (US)

Imatinib Mesylate (TW, UA, US)

Lapatinib (US, UA)

Pazopanib HCL (TW, US, UA, KR, CN, EU)

Rucaparib Camsylate(US)

Temozolomide (US, RU, TW, EU, KR, SG, CA, AU, CN, JP, BR, CEP)

Anti-inflammatory and Analgesic Agents

Balsalazide Disodium Dihydrate (US, TW, IN, KR)

Capsaicin (US, EU, TW, IN, TR, CA)

Nonivamide (EU)

Elagolix Sodium(US)

MRI Enhancing Agents

Gadodiamide (JP, TW, EU, RU, SA, TR, AL, BA)

Gadoterate Meglumine(US, CN)

Polymeric Drugs

Colesevelam HCl (US, TW, IN, TR, CN, UK, DE)

Sevelamer HCl (US, TW, IN, CA)

Sevelamer Carbonate (US, EU, TW, CA, IN, TR, AR, AU,CN, MY, KR, SG, SA, IL)

Patiromer Sorbitex Calcium(US, TW)

CNS Agents

Flupentixol Dihydrochlorid (TW, CN, IN)

Melitracen HCl(TW, CN, IN)

Taltirelin hydrate (JP)

Immunomodulators

Leflunomide (US, CEP, TW, CA, VN, MX, BR, RU, NZ)

Mycophenolate Mofetil (US, TW, IN, RU, KR)

Mycophenolate Sodium (US)

Teriflunomide (US, AU, TR, IL, CA)

Respiratory Agents

Benzonatate (US, TW, IN, MX, CN, SG)

Steroids

Levonorgestrel (US, TW, ZA, KZ, JP, UA, KR, BR)

Mifepristone (US, TW)

Vit. D Derivatives

Alfacalcidol (EU, TW, CN, SA, IN, RU, JP)

Calcifediol (CEP, US)

Calcipotriol Anhydrous (TW,US,CN,CEP,IN,CA,BY)

Calcipotriol Monohydrate (US, CEP, IN, TW, TR, SA, BY, DZ, MY, CN, CA)

Calcitriol (US, CEP, TW, CA, KR, IN, PK, BR, MX, JP, CN)

Doxercalciferol (US, TW)

Eldecalcitol

Maxacalcitol (JP, TW)

Paricalcitol (US, EU, TW, CN, KR, IN, IL, TR, MY, MK, NZ)

Antibiotics

Linezolid (US, EU, JP, CA, AU, TW, BR, CO, JO, ZW, KR, MY, ZA, CN)

Please be reminded that some products listed above are still patented and can only be made available for R & D use as permitted under 35 USC ¶ 271 (e) (1); Article 69, Paragraph 1 of the Patent Act of Japan; Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004; or Article 69 (5) of the Patent Law of People’s Republic of China; or Article 60 of the Patent Act of Republic of China. We will not make, sell, offer for commercial sale or export the products listed above in/into regions or countries in which substance patents are still existing and we will not be responsible if the use of any of the above products infringes on any patent in your country.